Product Description
Buy online the remarkably effective Carfilnat 60 Mg Injection (Carfilzomib), an exquisite anti-cancer chemotherapy solution by Natco Pharma Ltd. Formulated with 60 mg Carfilzomib per vial, this ravishing proteasome inhibitor offers ephemeral, targeted relief for adult patients battling multiple myeloma. Supplied as a single vial with white powder, it is suitable exclusively for intravenous infusion following reconstitution with sterile water. Prescription-only, odorless, and neutral in reconstituted pH, Carfilnat is ideal for hospital or clinical settings, ensuring professional administration and precise therapeutic impact. Store below 25C, protected from light.
Site of Application and Suitable Usage
Carfilnat 60 Mg Injection is meticulously designed for intravenous infusion, making it suitable solely for administration by healthcare professionals. The application surface is the vein, and it must be reconstituted with sterile water before use. Specifically tailored for adults, it targets patients with multiple myeloma. Due to its highly specialized nature, usage is confined to hospital or clinical environments, ensuring safety and compliance with medical protocols for optimal therapeutic results.
FOB Port, Delivery, and Payment Details
Carfilnat 60 Mg Injection is available for global shipment from leading FOB ports in India. With prompt transport services in place, typical delivery timelines range from 7 to 21 business days, depending on international location and customs clearance. Payment terms are flexible to accommodate business buyers, ensuring a smooth outlay for exporters, suppliers, and traders. Each shipment is carefully packed to preserve product integrity and ensure regulatory compliance throughout the transit process.
FAQ's of Carfilnat 60 Mg Injection ( Carfilzomib):
Q: How is Carfilnat 60 Mg Injection administered?
A: This injection is administered via intravenous infusion only, following reconstitution with sterile water, and must be given by a qualified healthcare professional in a hospital or clinical setting.
Q: What is the primary indication for using Carfilnat 60 Mg Injection?
A: Carfilnat 60 Mg Injection is primarily indicated for the treatment of multiple myeloma in adult patients, as part of an anti-cancer chemotherapy regimen.
Q: When should this medication be used?
A: Carfilnat should be used only after careful assessment and prescription by an oncologist or medical professional, typically as part of an ongoing cancer treatment protocol for eligible adults.
Q: Where should Carfilnat 60 Mg Injection be stored?
A: Store the vial below 25C (77F), keep it protected from light, and do not freeze. Proper storage ensures its efficacy throughout the 24-month shelf life.
Q: What are the handling and shipment precautions for Carfilnat?
A: Carfilnat is shipped in secure packaging from major Indian ports, and must be kept at controlled temperatures. Handling is strictly regulated to maintain safety, potency, and regulatory compliance during transport.
Q: How does Carfilnat benefit patients with multiple myeloma?
A: As a proteasome inhibitor, Carfilnat disrupts cancer cell growth, providing a targeted approach that can improve treatment outcomes in adults diagnosed with multiple myeloma.